Participants:18–64 years
Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Spain

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Autoimmune haemolytic anaemia

Not recruiting

Registered drug

Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Nipocalimab

Contact Research Centre

Heart failure with reduced ejection fraction

Not recruiting

Investigational

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Jtt-861 Monohydrochloride Dihydrate

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Neovascular age-related macular degeneration

Not recruiting

Registered drugNo placebo

Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Find therapies in clinical trials near you – page 26

470 trials match your criteria

Malignant peritoneal neoplasm+2

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Myelofibrosis+1

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Hormone-dependent prostate cancer

Study Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

Hormone-refractory prostate cancer

Study on Lutetium (177Lu) Vipivotide Tetraxetan for Men with Progressive Metastatic Castration-Resistant Prostate Cancer

Primary progressive multiple sclerosis

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Asthma

Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Multiple sclerosis+1

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Autoimmune haemolytic anaemia

Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

Heart failure with reduced ejection fraction

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Non-small cell lung cancer+2

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Neovascular age-related macular degeneration

Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.